CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers

PURPOSE: To determine the optimal chemotherapy backbone for testing in future US cooperative group studies for metastatic esophageal and gastroesophageal junction cancers. Cetuximab was added to each treatment arm based on promising preclinical data. PATIENTS AND METHODS: Patients with previously un...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Clin Oncol
Prif Awduron: Enzinger, Peter C., Burtness, Barbara Ann, Niedzwiecki, Donna, Ye, Xing, Douglas, Kathe, Ilson, David H., Villaflor, Victoria Meucci, Cohen, Steven J., Mayer, Robert J., Venook, Alan, Benson, Al Bowen, Goldberg, Richard M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Clinical Oncology 2016
Pynciau:
ORIGINAL REPORTS
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5019745/
https://ncbi.nlm.nih.gov/pubmed/27382098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.65.5092
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg